Actions
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.



Industrial Products
Plastic Products - Industrial
14,211 Cr
Low Risk
76.07
31.06
1.43
17.03
3,615.00
1,660.00
Sales CAGR
Profit CAGR
ROE
ROCE

View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Bearish
2
Neutral
8
Bullish
4
Bearish
16
Neutral
8
Bullish
22
Bearish
14
Neutral
0
Bullish
18
Shaily Engineering Plastics Ltd (SHAILY) is currently trading at 3,098.10 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Shaily Engineering Plastics Limited manufactures precision injection-moulded plastic components, assemblies, moulds and dies for healthcare, consumer and industrial customers. Its capabilities span high-performance polymers, clean-room production, automated assembly, tooling, metrology and advanced post-moulding services, supporting complex, high-volume OEM requirements from facilities concentrated in Gujarat and expanding internationally through Abu Dhabi and the United Kingdom. Healthcare has become Shaily Engineering Plastics Limited's primary growth engine, contributing 55% of quarterly revenue after growing 78% year-on-year. The company delivered 10.4 million devices in Q2 FY27 and expects to exceed its 36-million-device full-year target, with growth led by GLP-1 pen-injector programs while insulin volumes were temporarily deprioritized. Shaily Engineering Plastics Limited achieved record quarterly revenue of INR320 crore and crossed INR100 crore of EBITDA for the first time. Despite geopolitical freight pressures, polymer volatility and weak Western consumer demand, EBITDA margin remained broadly stable at 31.9%, demonstrating benefits from product mix, procurement discipline, pricing mechanisms and increasing healthcare contribution. The company is building a second growth platform beyond healthcare through consumer electronics and semiconductor packaging. Five electronics components are entering commercial scale, while semiconductor-tray trials are expected in Q3 FY27 and shipments in Q4 FY27. A Korean partnership and planned capacity additions provide a route into a technically demanding market, although revenue visibility remains undisclosed.
Over the past 52 weeks, Shaily Engineering Plastics Ltd has traded between a low of ₹1,660.00 and a high of ₹3,615.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Shaily Engineering Plastics Ltd has a market capitalization of approximately 14,211.32. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Shaily Engineering Plastics Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 76.07 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 14,211.32 Cr, Shaily Engineering Plastics Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Shaily Engineering Plastics Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Shaily Engineering Plastics Ltd is 76.07. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Shaily Toby Reusable is a two-step auto-injector system in which the patient retains the main mechanism for more than 200 injections. Each administration uses a separate pre-filled syringe pod that connects to the retained mechanism.
Shaily said FY27 volume should exceed 36 million pens but did not issue a revised numerical guidance range. Management said it expects to have greater visibility after the current quarter and may address the scale of the overrun on the next call.
Shaily Healthcare reached Rs 175 crore in Q2 FY27, up 78% year-on-year from Rs 99 crore. That lifted its share of consolidated revenue to 55%, versus 38% a year earlier. Management attributed the growth mainly to pen-injector platforms, particularly GLP-1 programmes.
Shaily plans to supply JEDEC trays, tapes, carrier tapes and wafer boxes. Management said Indian OSAT and TSAT facilities are expected to use combinations of trays and carrier tapes. It did not commit to every packaging format mentioned by analysts during the call.